Cargando…

Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?

CONTEXT: The number of metastatic lymph nodes (LNs) and the ratio of metastatic LN (LR) have been reported as predictors of recurrence in papillary thyroid carcinoma (PTC), while the role of LR or the number of metastatic LNs on the clinical response remains unclear. OBJECTIVE: We aimed to compare t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wen, Zhao, Teng, Liang, Jun, Lin, Yansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779777/
https://www.ncbi.nlm.nih.gov/pubmed/29505008
http://dx.doi.org/10.1097/MD.0000000000009664
_version_ 1783294609449811968
author Gao, Wen
Zhao, Teng
Liang, Jun
Lin, Yansong
author_facet Gao, Wen
Zhao, Teng
Liang, Jun
Lin, Yansong
author_sort Gao, Wen
collection PubMed
description CONTEXT: The number of metastatic lymph nodes (LNs) and the ratio of metastatic LN (LR) have been reported as predictors of recurrence in papillary thyroid carcinoma (PTC), while the role of LR or the number of metastatic LNs on the clinical response remains unclear. OBJECTIVE: We aimed to compare the prognostic value of LR and the number of metastatic LNs on clinical response in PTC. DESIGN/SETTING/PATIENTS: A total of 384 PTC patients with LN metastases were enrolled in this study, all of whom underwent total or near total thyroidectomy and subsequent radioiodine ablation. MAIN OUTCOME MEASURES: After a mean follow-up of 25.7 months, response to initial therapy was classified as excellent response (ER), indeterminate, biochemical incomplete or structural incomplete response. The scatter diagram and receiver operating characteristic (ROC) curve were respectively employed to identify and compare the clinical value of the number of metastatic LNs and LR for predicting ER in different number of dissected LNs (DLNs). Multivariate analyses were further performed to explore the indicator for ER. RESULTS: ER tended to be more concentrate in patients with lower LR and lower number of metastatic LNs in scatter diagram. Although in patients with ≤10 DLNs, LR presented higher area under the ROC curve than the number of metastatic LNs in predicting ER (LR: 0.687, LNs, 0.556, P = .02), whereas it turns opposite in those with >10 DLNs. In the multivariate analysis, LR (odds ratio [OR] = 1.037, P = .001) rather than the number metastatic LNs (OR = 0.752, P = .09) was an independent indicator for ER in addition to preablative-stimulated thyroglobulin (ps-Tg; OR = 1.056, P = .01) among patients with ≤10 DLNs. Although in patients with >10 DLNs, the number of metastatic LNs (OR = 1.062, P = .04) turned to be independent factor for ER, apart from ps-Tg (OR = 1.071, P = .00) and sex (OR = 0.570, P = .02). CONCLUSIONS: LR appears to be a better negative predictor for ER than the number of metastatic LNs in PTC patients with ≤10 DLNs, whereas the number of metastatic LNs is superior to LR in those with >10 DLNs.
format Online
Article
Text
id pubmed-5779777
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-57797772018-02-05 Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer? Gao, Wen Zhao, Teng Liang, Jun Lin, Yansong Medicine (Baltimore) 6800 CONTEXT: The number of metastatic lymph nodes (LNs) and the ratio of metastatic LN (LR) have been reported as predictors of recurrence in papillary thyroid carcinoma (PTC), while the role of LR or the number of metastatic LNs on the clinical response remains unclear. OBJECTIVE: We aimed to compare the prognostic value of LR and the number of metastatic LNs on clinical response in PTC. DESIGN/SETTING/PATIENTS: A total of 384 PTC patients with LN metastases were enrolled in this study, all of whom underwent total or near total thyroidectomy and subsequent radioiodine ablation. MAIN OUTCOME MEASURES: After a mean follow-up of 25.7 months, response to initial therapy was classified as excellent response (ER), indeterminate, biochemical incomplete or structural incomplete response. The scatter diagram and receiver operating characteristic (ROC) curve were respectively employed to identify and compare the clinical value of the number of metastatic LNs and LR for predicting ER in different number of dissected LNs (DLNs). Multivariate analyses were further performed to explore the indicator for ER. RESULTS: ER tended to be more concentrate in patients with lower LR and lower number of metastatic LNs in scatter diagram. Although in patients with ≤10 DLNs, LR presented higher area under the ROC curve than the number of metastatic LNs in predicting ER (LR: 0.687, LNs, 0.556, P = .02), whereas it turns opposite in those with >10 DLNs. In the multivariate analysis, LR (odds ratio [OR] = 1.037, P = .001) rather than the number metastatic LNs (OR = 0.752, P = .09) was an independent indicator for ER in addition to preablative-stimulated thyroglobulin (ps-Tg; OR = 1.056, P = .01) among patients with ≤10 DLNs. Although in patients with >10 DLNs, the number of metastatic LNs (OR = 1.062, P = .04) turned to be independent factor for ER, apart from ps-Tg (OR = 1.071, P = .00) and sex (OR = 0.570, P = .02). CONCLUSIONS: LR appears to be a better negative predictor for ER than the number of metastatic LNs in PTC patients with ≤10 DLNs, whereas the number of metastatic LNs is superior to LR in those with >10 DLNs. Wolters Kluwer Health 2018-01-19 /pmc/articles/PMC5779777/ /pubmed/29505008 http://dx.doi.org/10.1097/MD.0000000000009664 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 6800
Gao, Wen
Zhao, Teng
Liang, Jun
Lin, Yansong
Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?
title Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?
title_full Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?
title_fullStr Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?
title_full_unstemmed Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?
title_short Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?
title_sort is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779777/
https://www.ncbi.nlm.nih.gov/pubmed/29505008
http://dx.doi.org/10.1097/MD.0000000000009664
work_keys_str_mv AT gaowen istheratiosuperiortothenumberofmetastaticlymphnodesinaddressingtheresponseinpatientswithpapillarythyroidcancer
AT zhaoteng istheratiosuperiortothenumberofmetastaticlymphnodesinaddressingtheresponseinpatientswithpapillarythyroidcancer
AT liangjun istheratiosuperiortothenumberofmetastaticlymphnodesinaddressingtheresponseinpatientswithpapillarythyroidcancer
AT linyansong istheratiosuperiortothenumberofmetastaticlymphnodesinaddressingtheresponseinpatientswithpapillarythyroidcancer